HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lifan Liang Selected Research

Sarcoplasmic Reticulum Calcium-Transporting ATPases

11/2014The role of SUMO-1 in cardiac oxidative stress and hypertrophy.
7/2013Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension.
6/2011SERCA2a gene transfer decreases sarcoplasmic reticulum calcium leak and reduces ventricular arrhythmias in a model of chronic heart failure.
2/2007Transcoronary gene transfer of SERCA2a increases coronary blood flow and decreases cardiomyocyte size in a type 2 diabetic rat model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lifan Liang Research Topics

Disease

6Heart Failure
01/2019 - 03/2009
6Fibrosis (Cirrhosis)
01/2019 - 04/2011
5Myocardial Infarction
01/2018 - 01/2007
3Neoplasms (Cancer)
12/2021 - 01/2021
3Infarction (Infarctions)
01/2015 - 01/2007
2Reperfusion Injury
01/2019 - 04/2010
2Ischemia
01/2018 - 03/2013
1Myeloid Leukemia (Leukemia, Myelocytic)
12/2021
1Liver Neoplasms (Liver Cancer)
01/2021
1Hepatocellular Carcinoma (Hepatoma)
01/2021
1Cardiovascular Diseases (Cardiovascular Disease)
10/2020
1Brain Death (Brain Dead)
01/2019
1Multiple Myeloma
01/2019
1Necrosis
01/2019
1Hemorrhagic Shock
01/2019
1Thrombosis (Thrombus)
01/2019
1Primary Graft Dysfunction
01/2019
1Lung Injury
01/2019
1Pulmonary Arterial Hypertension
07/2013
1Vascular System Injuries
07/2013
1Right Ventricular Hypertrophy
07/2013
1Vascular Remodeling
07/2013
1Abdominal Aortic Aneurysm
09/2011
1Hypertrophy
08/2011
1Body Weight (Weight, Body)
08/2011
1Inflammation (Inflammations)
08/2011
1Heart Diseases (Heart Disease)
03/2009
1Type 2 Diabetes Mellitus (MODY)
02/2007
1Coronary Occlusion
01/2007

Drug/Important Bio-Agent (IBA)

4Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA
11/2014 - 02/2007
2Proteins (Proteins, Gene)FDA Link
12/2021 - 01/2016
2CateninsIBA
01/2021 - 11/2012
2Stem Cell FactorIBA
01/2015 - 11/2012
2CollagenIBA
08/2011 - 04/2011
1histone H3 trimethyl Lys4IBA
12/2021
1Glutamic Acid (Glutamate)FDA Link
12/2021
1MethyltransferasesIBA
12/2021
1Protein Kinases (Protein Kinase)IBA
01/2021
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
01/2021
1ErbB Receptors (EGF Receptor)IBA
01/2021
1omega-Chloroacetophenone (Mace)IBA
10/2020
1FibrinIBA
01/2019
1Indicators and Reagents (Reagents)IBA
01/2019
1LipidsIBA
01/2019
1Prostaglandins DIBA
01/2019
1Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2019
1ChloridesIBA
01/2018
1Protein Phosphatase 1IBA
10/2017
1UbiquitinIBA
11/2014
1Protein Isoforms (Isoforms)IBA
11/2014
1MonocrotalineIBA
07/2013
1GalactosidasesIBA
07/2013
1Green Fluorescent ProteinsIBA
09/2011
1ResistinIBA
08/2011
1Fibronectins (Fibronectin)IBA
08/2011
1Messenger RNA (mRNA)IBA
08/2011
1Connective Tissue Growth FactorIBA
08/2011
1CalciumIBA
06/2011
1Coloring Agents (Dyes)IBA
04/2011
1Peptides (Polypeptides)IBA
04/2011
1Carrier Proteins (Binding Protein)IBA
04/2011
1Fluorescent Dyes (Fluorescent Probes)IBA
04/2011
1C.I. direct red 80IBA
04/2011
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2010
1Small Interfering RNA (siRNA)IBA
03/2009
1phospholambanIBA
03/2009
1erucylphosphocholineIBA
01/2007
1salicylhydroxamic acid (SHAM)IBA
01/2007
1ErythropoietinFDA Link
01/2007

Therapy/Procedure

3Therapeutics
01/2021 - 01/2007
3Ligation
01/2018 - 03/2013
1Lung Transplantation
01/2019
1Injections
01/2015
1RNAi Therapeutics
03/2009